Assistant Professor Valery Ionin

Back

Assistant Professor Valery Ionin

Pavlov University, Saint-Petersburg (Russian Federation)

Presentations

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation?

Event: EHRA 2021

Topic: Pathophysiology and Mechanisms, Other

Session: Pathophysiology of atrial fibrillation and beyond II

Access

Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?

Event: ESC Congress 2019

Topic: Atrial Stressors

Session: Epidemiology of atrial fibrillation

Access

Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

Event: EHRA 2019

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Atrial Fibrillation - Treatment

Access

Epicardial adipose tissue and transforming growth factor-beta1 - risk factors of atrial fibrillation in patients with metabolic syndrome.

Event: EuroEcho-Imaging 2018

Topic: Technology

Session: Young Investigator Award session - Basic Science

Access

Left atrium fibrosis, epicardial fat and galectin-3 in patients with atrial fibrillation and metabolic syndrome

Event: ESC Congress 2018

Topic: Atrial Stressors

Session: Atrial fibrillation - epidemiology

Access

C(-915)G polymorphism gene of transforming growth factor 1 in patients with metabolic syndrome and atrial fibrillation

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity

Access

Epicardial fat and effectiveness of catheter radiofrequency ablation in patients with atrial fibrillation and metabolic syndrome

Event: EuroEcho-Imaging 2016

Topic: The echocardiographic examination and quality assessment

Session: The imaging examination and quality assessment

Access

Can we predict the effect of antiarrhythmic pharmacotherapy in atrial fibrillation and metabolic syndrome patients: focus on galectin-3

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Access

ESC 365 is supported by

Explore sponsored resources

Assistant Professor Valery Ionin Follow

Contributor content

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation?

Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?

Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

Epicardial adipose tissue and transforming growth factor-beta1 - risk factors of atrial fibrillation in patients with metabolic syndrome.

Left atrium fibrosis, epicardial fat and galectin-3 in patients with atrial fibrillation and metabolic syndrome

C(-915)G polymorphism gene of transforming growth factor 1 in patients with metabolic syndrome and atrial fibrillation

Epicardial fat and effectiveness of catheter radiofrequency ablation in patients with atrial fibrillation and metabolic syndrome

Can we predict the effect of antiarrhythmic pharmacotherapy in atrial fibrillation and metabolic syndrome patients: focus on galectin-3

ESC 365 is supported by

Assistant Professor Valery Ionin